JTV-519 hemifumarate

CAS : 145903-06-6

Ref. 3D-VFA90306

Informations sur le produit

• Nom: JTV-519 hemifumarate
• Synonymes: 1,4-Benzothiazepine, 2,3,4,5-tetrahydro-7-methoxy-4-[1-oxo-3-[4-(phenylmethyl)-1-piperidinyl]propyl]-, 1-(2,3-Dihydro-7-methoxy-1,4-benzothiazepin-4(5H)-yl)-3-[4-(phenylmethyl)-1-piperidinyl]-1-propanone, 1-Propanone, 1-(2,3-dihydro-7-methoxy-1,4-benzothiazepin-4(5H)-yl)-3-[4-(phenylmethyl)-1-piperidinyl]-, 4-[3-[1-(4-Benzyl)piperidinyl]propionyl]-7-methoxy-2,3,4,5-tetrahydro-1,4-benzothiazepine, Jtv-519, K-201, 4-[3-(4-Benzylpiperidin-1-yl)propionyl]-7-methoxy-2,3,4,5-tetrahydro-1,4-benzothiazepine

Description

JTV-519 is a novel compound that has the ability to increase energy metabolism in cells. It was created by altering the chemical structure of an existing drug, which is a cytosolic calcium channel blocker. JTV-519 has been shown to have a positive effect on cardiac function, as well as prevention of congestive heart failure. This drug also reduces diastolic pressure and improves renal function by increasing glomerular filtration rate. JTV-519 also interacts with toll-like receptor 2 and 4 (TLR2/4), which are molecules involved in inflammation and immune response. Experimental data suggests that JTV-519 may be useful for treating cardiovascular diseases such as atrial or ventricular arrhythmias, congestive heart failure, or cardiac hypertrophy.

• Marque: Biosynth

Propriétés chimiques

• Masse moléculaire: 482.63 g/mol
• Formule: C₂₅H₃₂N₂O₂S·5C₄H₄O₄
• Degré de pureté: Min. 95%